Manufacturer record
R. R. Medicare Products: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by R. R. Medicare Products (Jammu & Kashmir) were declared Not of Standard Quality between October 2021 and October 2021. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
2 records linked to R. R. Medicare Products in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Infusion Set | 060220Mfg 2020-02 · Exp 2025-01 | SterilitySterility | RDTL GuwahatiState lab | Oct 2021 |
| Infusion Set | 50220Mfg 2020-02 · Exp 2025-01 | Sterility & Bacterial EndotoxinSterility | RDTL GuwahatiState lab | Oct 2021 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.